請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/4941
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 魏志平 | |
dc.contributor.author | Tsai-Hsuan Hsieh | en |
dc.contributor.author | 謝采璇 | zh_TW |
dc.date.accessioned | 2021-05-15T17:50:29Z | - |
dc.date.available | 2016-08-25 | |
dc.date.available | 2021-05-15T17:50:29Z | - |
dc.date.copyright | 2014-08-25 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-08-19 | |
dc.identifier.citation | (US), N. C. for H. S. (1980). ICD-9-CM: International Classification of Diseases 9th Revision Clinical Modification. US Department of Health and Human Services, Public Health Service, Health Care Financing Administration.
Almenoff, J. S., Pattishall, E. N., Gibbs, T. G., DuMouchel, W., Evans, S. J. W., & Yuen, N. (2007). Novel statistical tools for monitoring the safety of marketed drugs. Clinical Pharmacology and Therapeutics, 82(2), 157–66. Azevedo, P. J., & Jorge, M. (2007). Comparing Rule Measures for Predictive Association Rules. In Machine Learning: ECML 2007 (pp. 510–517). Springer Berlin Heidelberg. Balakin, K. (2009). Pharmaceutical data mining: approaches and applications for drug discovery. John Wiley & Sons. Blei, D. M., Ng, A. Y., & Jordan, M. I. (2003). Latent Dirichlet Allocation. Journal of Machine Learning Research, 3, 993–1022. Cao, Y., Xu, J., Liu, T., Li, H., Huang, Y., & Hon, H. (2006). Adapting Ranking SVM to Document Retrieval. ACM SIGIR Conference, (49), 186–193. Cao, Z., Qin, T., Liu, T., Tsai, M., & Li, H. (2007). Learning to rank: from pairwise approach to listwise approach. Proceedings of the 24th International Conference on Machine Learning. Chapelle, O., & Keerthi, S. S. (2009). Efficient Algorithms for Ranking with SVMs. Information Retrieval Journal. Chen, L., Zeng, W.-M., Cai, Y.-D., Feng, K.-Y., & Chou, K.-C. (2012). Predicting Anatomical Therapeutic Chemical (ATC) classification of drugs by integrating chemical-chemical interactions and similarities. PloS One, 7(4), e35254. Choi, N., Chang, Y., Kim, J., Choi, Y., & Park, B. (2011). Comparison and validation of data-mining indices for signal detection : using the Korean national health insurance claims database. Pharmacoepidemiology and Drug Safety, 20, 1278–1286. Coloma, P. M., Trifiro, G., Patadia, V., & Sturkenboom, M. (2013). Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture? Drug Safety : An International Journal of Medical Toxicology and Drug Experience, 36(3), 183–97. Drug, N. (n.d.). Standard Operating Procedure. Http://pvtoolkit.org/toolkit/readers/sop_spontaneous_reporting.doc. Retrieved from http://pvtoolkit.org/toolkit/readers/sop_spontaneous_reporting.doc Evans, S. J., Waller, P. C., & Davis, S. (2001). Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiology and Drug Safety, 10(6), 483–486. Harpaz, R., Chase, H. S., & Friedman, C. (2010). Mining multi-item drug adverse effect associations in spontaneous reporting systems. BMC Bioinformatics. Harpaz, R., DuMouchel, W., Shah, N. H., Madigan, D., Ryan, P., & Friedman, C. (2012). Novel data-mining methodologies for adverse drug event discovery and analysis. Clinical Pharmacology and Therapeutics, 91(6), 1010–1021. Hauben, M., & Bate, A. (2009). Decision support methods for the detection of adverse events in post-marketing data. Drug Discovery Today, 14(7-8), 343–357. Hazell, L., & Shakir, S. A. W. (2006). Under-Reporting of Adverse A Systematic Review. Drug Safety : An International Journal of Medical Toxicology and Drug Experience, 29(5), 385–396. Health, I. N. P. (2006). The SAFETY of MEDICINES IN PUBLIC HEALTH PROGRAMMES: Pharmacovigilance an essential tool. World Health Organization. Hoerbst, a, & Ammenwerth, E. (2010). Electronic health records. A systematic review on quality requirements. Methods of Information in Medicine, 49(4), 320–336. Iyer, S. V, Lependu, P., Harpaz, R., Bauer-Mehren, A., & Shah, N. H. (2013). Learning signals of adverse drug-drug interactions from the unstructured text of electronic health records. AMIA Summits on Translational Science Proceedings AMIA Summit on Translational Science, 83–87. Lependu, P., Iyer, S. V, Fairon, C., & Shah, N. H. (2012). Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes. Journal of Biomedical Semantics, 3 Suppl 1(S5). Li, H. (2011). Learning to Rank for Information Retrieval and Natural Language Processing. Synthesis Lectures on Human Language Technologies (Vol. 4, pp. 1–113). Lin, W.-H., Wang, M.-C., Wang, W.-M., Yang, D.-C., Lam, C.-F., Roan, J.-N., & Li, C.-Y. (2014). Incidence of and mortality from Type I diabetes in Taiwan from 1999 through 2010: a nationwide cohort study. PloS One, 9(1), e86172. Lindquist, A. B. M., & Olsson, I. R. E. S. (1998). A Bayesian neural network method for adverse drug reaction signal generation. Pharmacoepidemiology and Prescription, 315–321. Liu, T.-Y. (2007). Learning to Rank for Information Retrieval. Foundations and TrendsR in Information Retrieval, 3(3), 225–331. Park, M. Y., Yoon, D., Lee, K., Kang, S. Y., Park, I., Lee, S. H., … Park, R. W. (2011). A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database. Pharmacoepidemiology and Drug Safety, 20, 598–607. Reps, J., Feyereisl, J., & Garibaldi, J. (2011). Investigating the detection of adverse drug events in a UK general practice electronic health-care database. UKCI 2011, the 11th Annual Workshop on Computational Intelligence, 167–173. Roughead, E. E. (1999). The nature and extent of drug-related hospitalisations in Australia. Journal of Quality in Clinical Practice, 19(1), 19–22. Strom, B. L. (2012). Overview of Automated Databases in Pharmacoepidemiology. In Pharmacoepidemiology (pp. 158–162). Chichester, UK: John Wiley & Sons. Szarfman, A., Machado, S. G., & O’Neill, R. T. (2002). Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. Drug Safety : An International Journal of Medical Toxicology and Drug Experience, 25(6), 381–392. Van der Hooft, C. S., Sturkenboom, M. C. J. M., van Grootheest, K., Kingma, H. J., & Stricker, B. H. C. (2006). Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Safety : An International Journal of Medical Toxicology and Drug Experience, 29(2), 161–168. Wang, Y., He, D., & Chen, W. (2013). A Theoretical Analysis of NDCG Ranking Measures. JMLR: Workshop and Conference Proceedings, 1–30. Yu, H., & Kim, S. (2012). SVM Tutorial : Classification , Regression , and Ranking. In Handbook of Natural Computing (pp. 479–506). Springer Berlin Heidelberg. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/4941 | - |
dc.description.abstract | 藥物不良反應是一個相當嚴重的全球性醫療問題,造成許多病人必須再度就醫,更嚴重的情況甚至導致死亡。因此,近年來受到許多國家的重視,進而推動藥物上市後的監控。起初,藥物上市後的監控是利用藥物不良反應通報系統來進行分析,但藥物不良反應通報系統是一個由醫護人員或是病人自行通報的系統,因此資料品質較難維護,並且可能有個人偏誤的報告。而後藥物上市後的監控轉向分析電子健康紀錄(Electronic Health Records),因為電子健康紀錄包含病患的電子病歷或健康保險申報相關之就診資料,其為持續性的資料,涵蓋的人口範圍也較廣,資料內容亦較準確。
台灣的健保資料庫是一個健康保險申報相關之資料庫,本研究以台灣健保資料庫來進行藥物副作用的分析與探測,希望能利用學習排序法將藥物和可能導致的不良反應(疾病)的關聯進行排序,找出可能的藥物不良反應。我們建立四個實驗情境以評估本研究所提出之方法效能,其結果顯示,本研究提出之方法能夠有效的提升探測藥物不良反應的準確度,可以提供給專業的醫藥學專家進行進一步的驗證與分析。 | zh_TW |
dc.description.abstract | Pharmacovigilance (PhV) is a serious issue worldwide, because adverse drug effects are serious problems that cause harms to patients or even death. Traditionally, PhV research focuses on detecting adverse drug effects from spontaneous reports systems (SRS), which contains reports voluntarily reported by medical professionals, patients, and pharmaceutical companies. However, the volunteer nature of SRS databases causes some limitations (e.g., overreporting, data incompleteness). Thus, the PhV research starts to investigate the use of electronic health records (EHR) databases for drug safety signal detection in recent years. In this study, we propose a novel EHR-based drug safety signal detection method on the basis of the learning to rank approach. In addition to multiple disproportional analysis measures, our proposed method also incorporates as additional ranking variables that capture implicit relations between drugs and diseases for decreasing the importance of non-drug-outcome signals. We use Taiwan’s national health insurance research database for drug safety signal detection. Our evaluation results suggest that our proposed method significantly outperforms existing disproportional analysis methods (each of which uses a single disproportional analysis measures). | en |
dc.description.provenance | Made available in DSpace on 2021-05-15T17:50:29Z (GMT). No. of bitstreams: 1 ntu-103-R01725025-1.pdf: 5342149 bytes, checksum: 001221177f853802f42fa37ae816f557 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 誌謝 i
中文摘要 ii ABSTRACT iii List of Figures vii List of Tables x Chapter 1 Introduction 1 1.1 Background 1 1.2 Research Motivation and Objective 4 Chapter 2 Literature Review 7 2.1 Spontaneous Reports Systems (SRSs) 7 2.1.1 Definition and famous examples of SRSs 7 2.1.2 Methods used on SRSs 8 2.1.3 Traits of SRSs 10 2.2 Electronic Health Records (EHR) databases 11 2.2.1 Definition and famous examples of EHR databases 11 2.2.2 Methods used on EHR databases 12 2.2.3 Traits of EHR databases 13 2.3 Research Gap 14 Chapter 3 Design of Our Ranking Method 18 3.1 Data Collection 19 3.2 Data Preparation 20 3.2.1 Data Preprocessing 21 3.2.2 Drug-Appearing Diagnosis (DAD) Generation 24 3.3 Learning System 25 3.3.1 Drug or Disease Group Mapping 26 3.3.2 Labeling Signals 26 3.3.3 Measure Calculation for Training Data 27 3.3.4 Summery of All Measures 34 3.3.5 Ranking Model Building 35 3.4 Detection System 37 3.4.1 Drug or Disease Grouping and Signal Generation 38 3.4.2 Measure Calculation for Candidate Signals 39 3.4.3 Rank Prediction 39 Chapter 4 Evaluation and Results 40 4.1 Experimental Data 40 4.2 Evaluation Design 44 4.2.1 Evaluation Criteria 44 4.2.2 Evaluation Procedure 46 4.3 Comparative Evaluation 47 4.4 Additional Evaluation 48 4.4.1 Experiment 1: Effects of Variables Selection 48 4.4.2 Experiment 2: Effects of Training Sizes 52 4.4.3 Experiment 3: Effects of Surveillance and Control Window Sizes 57 4.4.4 Experiment 4: Appropriateness of Non-Mono-Domain Training 63 Chapter 5 Conclusion and Future Work 68 References 71 | |
dc.language.iso | en | |
dc.title | 從台灣健保資料庫偵測藥物副作用: 使用學習排序法 | zh_TW |
dc.title | Detecting Drug Safety Signals from National Taiwan Health Insurance Research Database: A Learning to Rank Approach | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 蕭斐元,盧信銘,楊錦生 | |
dc.subject.keyword | 藥物不良反應,資料探勘,台灣健保資料庫, | zh_TW |
dc.subject.keyword | Pharmacovigilance,Data mining,NHIRD, | en |
dc.relation.page | 74 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2014-08-20 | |
dc.contributor.author-college | 管理學院 | zh_TW |
dc.contributor.author-dept | 資訊管理學研究所 | zh_TW |
顯示於系所單位: | 資訊管理學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf | 5.22 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。